Filing Details

Accession Number:
0001415889-24-000913
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-10 16:06:30
Reporting Period:
2024-01-08
Accepted Time:
2024-01-10 16:06:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070081 Ptc Therapeutics Inc. PTCT Pharmaceutical Preparations (2834) 043416587
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1686217 Scott Lee Golden C/O Ptc Therapeutics, Inc.
South Plainfield NJ 07066
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-01-08 775 $28.64 39,139 No 4 S Direct
Common Stock Disposition 2024-01-09 1,225 $29.01 37,914 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 2,666 RSUs from a January 5, 2023 grant of 10,640 RSUs.
  2. Includes 327 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2023 and 301 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2023.
  3. Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 990 RSUs from a January 6, 2021 grant of 3,960 RSUs and the vesting of 3,539 RSUs from January 7, 2022 grants totaling14,155 RSUs.